M&A Deal Summary

Varian Medical Systems Acquires Calypso Medical Technologies

On September 19, 2011, Varian Medical Systems acquired medical products company Calypso Medical Technologies from Bay City Capital and Nexus Life Science Partners for 10M USD

Acquisition Highlights
  • This is Varian Medical Systems’ 2nd transaction in the Medical Products sector.
  • This is Varian Medical Systems’ 10th largest (disclosed) transaction.
  • This is Varian Medical Systems’ 4th transaction in the United States.
  • This is Varian Medical Systems’ 1st transaction in Washington.

M&A Deal Summary
Date 2011-09-19
Target Calypso Medical Technologies
Sector Medical Products
Buyer(s) Varian Medical Systems
Sellers(s) Bay City Capital
Nexus Life Science Partners
Deal Type Add-on Acquisition
Deal Value 10M USD

Target

Calypso Medical Technologies

Seattle, Washington, United States
Calypso Medical Technologies is a medical device company.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Varian Medical Systems

Palo Alto, California, United States
Category Company
Founded 1948
Sector Medical Products
Revenue 3.2B USD (2020)
DESCRIPTION
Varian's corporate headquarters in Palo Alto, California.
Varian's corporate headquarters in Palo Alto, California.

Varian Medical Systems is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems was formed in 1948 and is based in Palo Alto, California.

DEAL STATS #
Overall 7 of 25
Sector (Medical Products) 2 of 9
Type (Add-on Acquisition) 7 of 22
State (Washington) 1 of 1
Country (United States) 4 of 13
Year (2011) 1 of 1
Size (of disclosed) 10 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-04-03 ACCEL Instruments

Bergisch Gladbach, Germany

ACCEL Instruments GmbH is a supplier of proton therapy systems for cancer treatment and scientific research instruments.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-03-05 InfiMed

Liverpool, New York, United States

InfiMed develops and supplies X-ray equipment manufacturers around the globe with specialized software and hardware for medical imaging applications, including radiography and fluoroscopy, digital radiography, cardiology and angiography.

Buy $15M

Seller(S) 2

SELLER

Bay City Capital

San Rafael, California, United States

Investor Investor Investor Investor Investor

Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.

DEAL STATS #
Overall 34 of 62
Sector (Medical Products) 6 of 10
Type (Add-on Acquisition) 19 of 31
State (Washington) 4 of 4
Country (United States) 32 of 59
Year (2011) 2 of 3
Size (of disclosed) 18 of 18
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-02 Epocrates

San Mateo, California, United States

Epocrates is a developer of medical application among U.S. physicians for clinical content, practice tools, and health industry engagement at the point of care.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-09-23 Aragon Surgical

Palo Alto, California, United States

Aragon Surgical, Inc. is a manufacturers of surgical instruments and sterilization container systems.

Sell -
SELLER

Nexus Life Science Partners

New York, New York, United States
Category Growth Capital Firm
Founded 2001
Size Small
Type Sector Focused
DESCRIPTION

Nexus Life Science Partners is a private equity firm that targets private and public healthcare companies located within the United States and around the world. The Firm's focus is on the growth segments of the healthcare industry. In particular, Nexus looks for product-driven life sciences companies developing breakthrough therapeutics for clinical needs, positively altering disease course and associated costs. The firm seeks for each private investment a potential for liquidity within 24 months after initial investment, as well as a 2-3 times return on invested capital. Nexus Life Science Partners was formed in 2001, and is based in New York, New York.

DEAL STATS #
Overall 18 of 22
Sector (Medical Products) 3 of 3
Type (Add-on Acquisition) 9 of 10
State (Washington) 1 of 1
Country (United States) 16 of 19
Year (2011) 4 of 4
Size (of disclosed) 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-07 Salient Surgical Technologies

Portsmouth, New Hampshire, United States

Salient Surgical provides devices that reduce surgical blood loss, reducing the need for transfusion. Utilizing Salient's saline-enhanced radio-frequency technology allows surgeons to control bleeding without charring and improve patient outcomes. Tissue is being sealed during liver resections, as well as orthopedic and spinal surgeries.

Sell $525M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-05-01 Aryx Therapeutics

Fremont, California, United States

Aryx Therapeutics is a pharmaceutical company that uses retro-metabolic drug design to enhance drug safety, exploiting opportunities provided by the slow and/or toxic metabolism of top-selling drugs. Aryx Therapeutics was founded in 1997 and is based in Fremont, California.

Sell -
Mergr

Product

Company

Legal